Cotadutide | Dual GLP-1/glucagon receptor agonist

Chemical Structure : Cotadutide

CAS No.: 1686108-82-6

Cotadutide (MEDI-0382, MEDI0382)

Catalog No.: PC-72605Not For Human Use, Lab Use Only.

Cotadutide (MEDI-0382, MEDI0382) is a potent dual GLP-1/glucagon receptor peptide agonist with EC50 values of 6.9 pM and 10.2 pM, respectively.

Packing	Price	Stock
5 mg	$458	In stock
10 mg	$728	In stock
25 mg		Get quote
100 mg		Get quote

Get Quotation Now

* Please select Quantity before adding items.

or Bulk Inquiry

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Biological Activity

Cotadutide (MEDI-0382, MEDI0382) is a potent dual GLP-1/glucagon receptor peptide agonist with EC50 values of 6.9 pM and 10.2 pM, respectively.

Cotadutide (MEDI-0382, MEDI0382) stimulates a concentration-dependent increase in cAMP accumulation in rat (INS-1 832/3) and human (EndoC-βH1) β-cell lines (EC50: 226 pM and 1051 pM, respectively ), as well as rat, mouse and human hepatocytes (EC50: 462 pM, 840 pM, 1447 pM, respectively).

Cotadutide (MEDI-0382, MEDI0382) potentiates glucose-stimulated insulin secretion in the rat (INS-1 832/3) pancreatic β‐cell line and increases glucose output in rat hepatocytes.

Cotadutide (MEDI-0382, MEDI0382) induces mitochondrial turnover and enhances mitochondrial function in mouse primary hepatocytes.

Cotadutide (MEDI-0382, MEDI0382) (10- 30 nmol/kg, s.c.) suppresses food intake and reduces body weight in DIO mice, reduces hepatic fibrosis and inflammation in in ob/ob AMLN NASH mice.

Physicochemical Properties

M.Wt	3728.0
Formula	C167H252N42O55
Appearance	Solid
CAS No.
Storage	Solide Powder -20°C 12 Months; 4°C 6 Months	In Solvent -80°C 6 Months; -20°C 6 Months
Shipping
Solubility	10 mM in DMSO (37.3 mg/mL)
Chemical Name/SMILES	H-His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Lys(1)-Ser-Glu-Tyr-Leu-Asp-Ser-Glu-Arg-Ala-Arg-Asp-Phe-Val-Ala-Trp-Leu-Glu-Ala-Gly-Gly-OH.palmitoyl-Glu(1)-OH

References

1. Henderson SJ, et al. Diabetes Obes Metab. 2016 Dec;18(12):1176-1190.

2. Ambery PD, et al. Br J Clin Pharmacol. 2018 Oct;84(10):2325-2335.

3. Ambery P, et al. Lancet. 2018 Jun 30;391(10140):2607-2618.

4. Boland ML, et al. Nat Metab. 2020 May;2(5):413-431.

Select Your Country or Region

Cotadutide (MEDI-0382, MEDI0382)

Biological Activity

Physicochemical Properties

References

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

Get Quote

* Indicates a Required FieldYour information is safe with us.